Jean Borges Bertoldo

Dr. Jean Borges Bertoldo

Institute for Molecular Medicine, Martin Luther University Halle-Wittenberg, 06108 Halle, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2018 in Journal of the American Chemical Society
Verified
Journal Article
Open access
MMMaria Matos
Maria Matos
BOBruno Oliveira
Bruno Oliveira
NMNuria Martínez-Sáez
Nuria Martínez-Sáez
AGAna Guerreiro
Ana Guerreiro
PCPedro M. S. D. Cal
Pedro M. S. D. Cal
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
Site-selective chemical conjugation of synthetic molecules to proteins expands their functional and therapeutic capacity. Current protein modification methods, based on both synthetic and biochemical technologies, can achieve site-selectivity, but these techniques often require extensive sequence engineering or are restricted to the N- or C-terminus. Here we show the computer-assisted design of sulfonyl acrylate reagents for the modification of a single lysine residue on native protein sequences. This feature of the designed sulfonyl acrylates, together with the innate and subtle reactivity differences conferred by the unique local microenvironment surrounding each lysine, contribute to the observed regioselectivity of the reaction. Moreover, this site-selectivity was predicted computationally, where the lysine with the lowest pKa was the kinetically favoured residue at slightly basic pH. Chemoselectivity was also observed as the reagent reacted preferentially at lysine, even in those cases when other nucleophilic residues such as cysteine were present. The reaction is fast and proceeds using a single molar equivalent of the sulfonyl acrylate reagent under biocompatible conditions (37 ºC and pH 8.0). This technology was demonstrated by the quantitative and irreversible modification of five different proteins including the clinically used therapeutic antibody Trastuzumab without prior sequence engineering. Importantly, their natural secondary structure and functionality is retained after the modification. This regioselective lysine modification method allows for further bioconjugation through aza-Michael addition to the acrylate electrophile that is generated by spontaneous elimination of methanesulfinic acid upon lysine labelling. We showed that a protein and an antibody conjugate bearing a site-specifically installed fluorophore at lysine could be used for selective imaging of apoptotic cells and detection of Her2+ cells, respectively. This simple and robust method does not require genetic engineering and may be generally used for accessing diverse, well-defined protein conjugates for basic biology and therapeutic studies.

7 January 2015 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
OLOlivier Lamotte
Olivier Lamotte
JBJean Borges Bertoldo
Jean Borges Bertoldo
ABAngã©Lique Besson-Bard
Angã©Lique Besson-Bard
CRClaire Rosnoblet
Claire Rosnoblet
SASã©Bastien Aimã©
Sã©Bastien Aimã©
DWDavid Wendehenne
David Wendehenne
The role of nitric oxide (NO) as a major regulator of plant physiological functions has become increasingly evident. To further improve our understanding of its role, within the last few years plant biologists have begun to embrace the exciting opportunity of investigating protein S-nitrosylation, a major reversible NO-dependent post-translational modification (PTM) targeting specific Cys residues and widely studied in animals. Thanks to the development of dedicated proteomic approaches, in particular the use of the Biotin Switch Technique (BST) combined with mass spectrometry, hundreds of plant protein candidates for S-nitrosylation have been identified. Functional studies focused on specific proteins provided preliminary comprehensive views of how this PTM impacts the structure and function of proteins and, more generally, of how NO might regulate biological plant processes. The aim of this review is to detail the basic principle of protein S-nitrosylation, to provide information on the biochemical and structural features of the S-nitrosylation sites and to describe the proteomic strategies adopted to investigate this PTM in plants. Limits of the current approaches and tomorrow's challenges are also discussed.

26 September 2012 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
JAJéremy Astier
Jéremy Astier
ABAngélique Besson-Bard
Angélique Besson-Bard
OLOlivier Lamotte
Olivier Lamotte
JBJean Borges Bertoldo
Jean Borges Bertoldo
SBStéphane Bourque
Stéphane Bourque
DWDavid Wendehenne
David Wendehenne
NO has important physiological functions in plants, including the adaptative response to pathogen attack. We previously demonstrated that cryptogein, an elicitor of defence reaction produced by the oomycete Phytophthora cryptogea, triggers NO synthesis in tobacco. To decipher the role of NO in tobacco cells elicited by cryptogein, in the present study we performed a proteomic approach in order to identify proteins undergoing S-nitrosylation. We provided evidence that cryptogein induced the S-nitrosylation of several proteins and identified 11 candidates, including CDC48 (cell division cycle 48), a member of the AAA+ ATPase (ATPase associated with various cellular activities) family. In vitro, NtCDC48 (Nicotiana tabacum CDC48) was shown to be poly-S-nitrosylated by NO donors and we could identify Cys110, Cys526 and Cys664 as a targets for S-nitrosylation. Cys526 is located in the Walker A motif of the D2 domain, that is involved in ATP binding and was previously reported to be regulated by oxidative modification in Drosophila. We investigated the consequence of NtCDC48 S-nitrosylation and found that NO abolished NtCDC48 ATPase activity and induced slight conformation changes in the vicinity of Cys526. Similarly, substitution of Cys526 by an alanine residue had an impact on NtCDC48 activity. More generally, the present study identified CDC48 as a new candidate for S-nitrosylation in plants facing biotic stress and further supports the importance of Cys526 in the regulation of CDC48 by oxidative/nitrosative agents.

1 September 2009 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
TBTiago Bortolotto
Tiago Bortolotto
JBJean Borges Bertoldo
Jean Borges Bertoldo
FSFernanda Zanette da Silveira
Fernanda Zanette da Silveira
TDTamires Manganelli Defaveri
Tamires Manganelli Defaveri
JSJacira Silvano
Jacira Silvano
CPClaus Tröger Pich
Claus Tröger Pich

7 April 2023 in Drug Discovery Today
Verified
Journal Article
Closed access
JBJean Borges Bertoldo
Jean Borges Bertoldo
SMSimon Müller
Simon Müller
SHStefan Hüttelmaier
Stefan Hüttelmaier

12 April 2018 in Cancer Research
Verified
Journal Article
Open access
PDF file
SRSabrina Romagny
Sabrina Romagny
SBSarra Bouaouiche
Sarra Bouaouiche
GLGéraldine Lucchi
Géraldine Lucchi
PDPatrick Ducoroy
Patrick Ducoroy
JBJean Borges Bertoldo
Jean Borges Bertoldo
Stéphanie PlenchetteStéphanie Plenchette
Stéphanie Plenchette
TNFα is a prominent proinflammatory cytokine and a critical mediator for the development of many types of cancer such as breast, colon, prostate, cervical, skin, liver, and chronic lymphocytic leukemia. Binding of TNFα to TNFR1 can lead to divergent signaling pathways promoting predominantly NF-κB activation but also cell death. We report here that the nitric oxide (NO) donor glyceryl trinitrate (GTN) converts TNFα, generated from immune cells or cancer cells stimulated by chemotherapy, into a prodeath mediator in colon and mammary cancer cells. GTN-mediated S-nitrosylation of cIAP1 on cysteines 571 and 574 inhibited its E3 ubiquitin ligase activity, which in turn reduced Lys63-linked ubiquitination of RIP1 and initiated assembly of a death complex. These findings provide insights into how NO can harness advantageous aspects of inflammation in cancer and provide new therapeutic strategies. Significance: Combination of an NO donor with chemotherapeutic drug–induced TNFα represents a potentially valuable anticancer strategy. Cancer Res; 78(8); 1948–57. ©2018 AACR.